Tushar Pandey Awarded for His Enourmous Contribution to Hematology
Tushar Pandey, Editorial Board Member of Journal of Cancer Chemotherapy, shared on Facebook:
”I am honored to be awarded by the Honourable Chief Minister of Uttarakhand, Shri Pushkar Singh Dhami ji, in recognition of my work in Hematology and Hemato-Oncology across Kumaon, Uttarakhand, and the adjoining regions of Uttar Pradesh.
This recognition represents more than a personal milestone.
It reaffirms a deliberate choice I made early in my career—to build advanced, evidence-based hematology and cancer care in Haldwani, ensuring that patients from the hills and nearby regions have access to world-class treatment closer to home, rather than limiting practice to metro cities or opportunities abroad.
Over the years, the focus has remained constant: delivering ethical, guideline-driven, and outcome-oriented care for complex blood disorders and cancers, while strengthening regional capacity in Hematology, Hemato-Oncology, Bone Marrow Transplantation, and advanced cellular therapies.
I am deeply grateful to my patients and their families for their trust, and to my colleagues, nursing teams, technicians, hospital partners, and support staff for their unwavering commitment.
I also acknowledge my mentors and well-wishers, whose guidance has been invaluable.
Meaningful outcomes are always the result of strong teamwork.
This honor reinforces my responsibility to continue contributing to clinical excellence, innovation, and compassionate care for our region.
With gratitude and renewed commitment.”

More winner stories featured in Hemostasis Today.
-
Nov 19, 2026, 07:00Rucha Patil: Highlights in Science and Collaboration at Haematocon 2026
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease
-
Nov 19, 2026, 05:31Lance Reed: One Donation, Multiple Lives
-
Nov 19, 2026, 05:20ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis